³ÉÈËVRÊÓƵ

Frédéric J. Veyrier

Frédéric J. Veyrier, Ph.D.
Professeur,
INRS-Institut Armand-Frappier
Institut National de la Recherche Scientifique
Université du Québec
531 boul. des Prairies
Laval, Québec, Canada
H7V 1B7

tel: 1 (450) 687 5010 # 8831
email: frederic.veyrier [at] iaf.inrs.ca

Research


Focus

  • Bacterial symbiotes evolution:
    Ìý Ìý Ìý- Neisseria meningitidis and other nasopharyngeal pathogens
    Ìý Ìý Ìý- Mycobacterium tuberculosis
    Ìý Ìý Ìý-ÌýHelicobacter pylori
  • Bacterial ecology
  • Bacteria-bacteria interactions (bactericidal weapons, molecular shields)
  • Pathogens cell wall

Keywords

Bacteria, virulence, evolution, bacterial interaction, microbial ecology

Selected Publications

  • Williams AH, Veyrier FJ, Bonis M, Michaud Y, Raynal B, Taha MK, Haouz A & BonecaÌýIG*. Visualization of a substrate-induced catalytic triad of the Neisseria meningitidis ±è±ð±è³Ù¾±»å´Ç²µ±ô²â³¦²¹²ÔÌýO-acetylesterase reveals mechanistic conservation in the SGNH esterase family member. ´¡³¦³Ù²¹ÌýCrystallogr D Biol Crystallogr. 2014 in press
  • Radomski N, Roguet A, Lucas FS, Veyrier FJ, Cambau E, Accrombessi H, Moilleron R, BehrÌýMA & Moulin L*.Ìý. BMC microbiology, 2013, Dec 3;13:277.
  • Veyrier FJ, Ecobichon C, Boneca IG*. Ìý. Genome announc, 2013, Dec 19;1(6). pii: e01095-13.
  • Veyrier FJ*, Hong E, Deghmane AE, Taha MK*. . Genome announc, 2013, Oct 3;1(5). pii: e00795-13.
  • Hansen JM, Golchin SA, Veyrier FJ, Domenech P, Boneca IG, Azad AK, Rajaram MVS,ÌýSchlesinger LS, Divangahi M, Reed MB & Behr MA*. . J Infect Dis, 2013, Dec 19.Ìý[Epub ahead of print]
  • Veyrier FJ*, Williams A, Mesnage S, Schmitt C, Taha MK & Boneca IG*. Mol Microbiol, 2013, Mar;87(5):1100-12.
  • Hong E, Hedberg ST, Abad R, Fazio C, Enríquez R, Deghmane AE, Jolley KA, StefanelliÌýP, Unemo M, Vazquez J, Veyrier FJ & Taha MK*. . Antimicrob Agents Chemother,Ìý2013, Apr;57(4):1961-4.
  • Veyrier FJ*, Boneca IG, Cellier MF & Taha MK.ÌýPLOS Pathog, 2011, 7:e1002261
  • Veyrier F, Pletzer D, Turenne C & Behr MA*. . BMC Evol Biol, 2009, 9:1961
  • Coulombe F, Divangahi M, Veyrier FJ, de Léséleuc L, Gleason J, Yang Y, Kelliher MA,ÌýPandey AK, Sassetti CM, Reed MB & Behr MA*. J Exp Med, 2009, 206:1709-16
  • Divangahi M, Coulombe F, Mostowy S, Kosak R, Veyrier F, Guillot L, Reed MB, GleasonÌýJ, Kobayashi KS, Flavell RA, Gros P & Behr MA*. . J Immunol,Ìý2008, 181:7157-65
  • Veyrier F, Said-Salim B & Berh MA*.. JÌýBacteriol, 2008, 190:1891-9
  • Chaloupka R, Courville P, Veyrier F, Knudsen B, Tompkins TA & Cellier MF*. . Biochemistry, 2005, 44:726-33
  • Courville P, Chaloupka R, Veyrier F & Cellier MF*. . J Biol Chem, 2004, 279:3318-26

Reviews

  • Guilhen C, Taha MK & Veyrier FJ*. . Front Cell Infect Microbiol, 2013, 10.3389/fcimb.2013.00102
  • Veyrier FJ, Dufort A & Behr MA*. . Trends Microbiol, 2011, 19:156-61

Book chapters

  • Wheeler R, Veyrier FJ, Werts C, Boneca IG*. Peptidoglycan and Nod receptors.Ìý

External Links

Ìý

,Ìý,Ìý,Ìý

Ìý

Ìý

Ìý

Ìý

Back to top